ENTERPRISE FINANCIAL SERVICES CORP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
ENTERPRISE FINANCIAL SERVICES CORP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$3,000
+50.0%
34
-2.9%
0.00%
Q1 2021$2,000
-33.3%
35
+2.9%
0.00%
-100.0%
Q4 2020$3,000
+200.0%
340.0%0.00%
Q3 2020$1,0000.0%340.0%0.00%
Q2 2020$1,000340.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders